Hong Kong Covid-19 patients who are aged 60 and above or who have severe immune deficiency, as well as other unvaccinated high-risk individuals, could be treated with oral drugs molnupiravir and Paxlovid, the Hospital Authority has said. Both antiviral drugs have been shown to reduce risk of hospitalisation with Covid-19. The use of the two […]
